TREATMENT-FREE REMISSION IN SEVERE SYSTEMIC LUPUS-ERYTHEMATOSUS FOLLOWING SYNCHRONIZATION OF PLASMAPHERESIS WITH SUBSEQUENT PULSE CYCLOPHOSPHAMIDE

被引:114
作者
EULER, HH
SCHROEDER, JO
HARTEN, P
ZEUNER, RA
GUTSCHMIDT, HJ
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,KIEL,GERMANY
[2] MUNICIPAL HOSP,KIEL,GERMANY
来源
ARTHRITIS AND RHEUMATISM | 1994年 / 37卷 / 12期
关键词
D O I
10.1002/art.1780371212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the effect of an intensified treatment protocol synchronizing plasmapheresis with subsequent pulse cyclophosphamide for severe systemic lupus erythematosus (SLE). Methods. A protocol of plasmapheresis (3 x 60 ml/kg) and subsequent high-dose pulse cyclophosphamide (36 mg/kg) followed by 6 months of peroral immunosuppression was used to treat 14 patients with severe SLE. Results. Rapid improvement was achieved in all patients. Immunosuppressants, including corticosteroids, were withdrawn at month 6 in 12 patients. Eight patients continued without treatment for a mean observation period of 5.6 years (46-91 months). Conclusion. The results demonstrate that treatment-free clinical remission can be achieved in some patients with severe SLE.
引用
收藏
页码:1784 / 1794
页数:11
相关论文
共 46 条
[1]   STUDIES ON CYCLOPHOSPHAMIDE-INDUCED TOLERANCE TO SHEEP ERYTHROCYTES [J].
AISENBERG, AC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1967, 125 (05) :833-+
[2]   IMMUNOLOGICAL TOLERANCE INDUCED BY CYCLOPHOSPHAMIDE ASSAYED BY PLAQUE SPLEEN CELL METHOD [J].
AISENBERG, AC ;
WILKES, B .
NATURE, 1967, 213 (5075) :498-+
[3]   THERAPY OF LUPUS NEPHRITIS - CONTROLLED TRIAL OF PREDNISONE AND CYTOTOXIC DRUGS [J].
AUSTIN, HA ;
KLIPPEL, JH ;
BALOW, JE ;
LERICHE, NGH ;
STEINBERG, AD ;
PLOTZ, PH ;
DECKER, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (10) :614-619
[4]   MALIGNANCY FOLLOWING TREATMENT OF RHEUMATOID-ARTHRITIS WITH CYCLOPHOSPHAMIDE - LONG-TERM CASE-CONTROL FOLLOW-UP-STUDY [J].
BAKER, GL ;
KAHL, LE ;
ZEE, BC ;
STOLZER, BL ;
AGARWAL, AK ;
MEDSGER, TA .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (01) :1-9
[5]   PLASMAPHERESIS AND PULSE CYCLOPHOSPHAMIDE IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
BARR, WG ;
HUBBELL, EA ;
ROBINSON, JA .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (01) :152-153
[6]   RISK FOR SUSTAINED AMENORRHEA IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS RECEIVING INTERMITTENT PULSE CYCLOPHOSPHAMIDE THERAPY [J].
BOUMPAS, DT ;
AUSTIN, HA ;
VAUGHAN, EM ;
YARBORO, CH ;
KLIPPEL, JH ;
BALOW, JE .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :366-369
[7]   CONTROLLED TRIAL OF PULSE METHYLPREDNISOLONE VERSUS 2 REGIMENS OF PULSE CYCLOPHOSPHAMIDE IN SEVERE LUPUS NEPHRITIS [J].
BOUMPAS, DT ;
AUSTIN, HA ;
VAUGHN, EM ;
KLIPPEL, JH ;
STEINBERG, AD ;
YARBORO, CH ;
BALOW, JE .
LANCET, 1992, 340 (8822) :741-745
[8]  
BYRSTYN JC, 1971, PROGR IMMUNOLOGY
[9]   DESPERATE DISEASES AND PLASMAPHERESIS [J].
CAMPION, EW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (21) :1425-1427
[10]  
CHANG H, 1969, J IMMUNOL, V102, P37